Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Weight Loss, Splenomegaly, and Hypocholesterolemia in Myeloproliferative Neoplasms: Patterns and Relevance from the Pre JAK2 Inhibitor Era.

Ruben A. Mesa, MD, Susan Schwager, Jocelin Huang, MD, Animesh D. Pardanani, MBBS, PhD, Kebede Hussein, MD, John Camoriano, MD, Ayalew Tefferi, MD

Blood (2009) 114 (22): 3918.

https://doi.org/10.1182/blood.V114.22.3918.3918

Published: 2009

Journal Articles

Red Blood Cell Transfusion Requirement at Diagnosis Adversely Affects Both Overall and Leukemia-Free Survival in Primary Myelofibrosis - Increased Serum Ferritin or Total Transfusion Burden Does Not

Ayalew Tefferi, MD, Ruben A. Mesa, MD, FACP, Jocelin Huang, MD, Animesh D. Pardanani, MBBS, PhD, Kebede Hussein, MD, Susan Schwager, Curtis A. Hanson, David P. Steensma, MD, FACP

Blood (2008) 112 (11): 5232.

https://doi.org/10.1182/blood.V112.11.5232.5232

Published: 2008

Journal Articles

Dynamics, and Prognostic Impact, of Weight Loss in Primary Myelofibrosis

Ruben A. Mesa, MD, FACP, Susan Schwager, Jocelin Huang, MD, Kebede Hussein, MD, Animesh D. Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 5224.

https://doi.org/10.1182/blood.V112.11.5224.5224

Published: 2008

Journal Articles

Hypocholesterolemia Is Independently Associated with Decreased Survival in Patients with Primary Myelofibrosis: An Analysis of Lipid Profiles in 558 Myeloproliferative Patients.

Ruben A. Mesa, MD, Jocelin Huang, MD, Susan Schwager, Animesh Pardanani, MD, Kebede Hussein, MD, David Dingli, MD, Michael Jensen, MD, Elizabeth Haglind, MD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 2548.

https://doi.org/10.1182/blood.V110.11.2548.2548

Published: 2007

Journal Articles

Erythropoietin Therapy Does Not Benefit Transfusion-Dependent Primary Myelofibrosis Patients and Treatment Response Is Infrequent with a Baseline Hemoglobin Level ≥ 10 g/dL.

Jocelin Huang, MD, Terra L. Lasho, MT(ASCP), Chin Yang Li, MD, Animesh D. Pardanani, MD, PhD, Ruben A. Mesa, MD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 3555.

https://doi.org/10.1182/blood.V110.11.3555.3555

Published: 2007

Journal Articles

Low JAK2 V617F Allele Burden in Primary Myelofibrosis, Compared to Either a Higher Allele Burden or Unmutated Status, Predicts Inferior Overall and Leukemia-Free Survival.

Ayalew Tefferi, MD, Terra L. Lasho, MT(ASCP), Jocelin Huang, MD, Christy Finke, Curtis A. Hanson, MD, Ruben A. Mesa, MD, Animesh Pardanani, MD, PhD

Blood (2007) 110 (11): 676.

https://doi.org/10.1182/blood.V110.11.676.676

Published: 2007

Journal Articles

Erythropoiesis Stimulating Agents and the Risk of Leukemic Transformation in Primary Myelofibrosis.

Jocelin Huang, MD, Chin-Yang Li, MD, Ruben A. Mesa, MD, Wenting Wu, PhD, Curtis A. Hanson, MD, Animesh D. Pardanani, MD, PhD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 554.

https://doi.org/10.1182/blood.V110.11.554.554

Published: 2007

Journal Articles

The Presence of the JAK2 V617F Mutation in Primary Myelofibrosis and Its Allele Burden in Polycythemia Vera Predict Chemosensitivity to Hydroxyurea.

Shireen Sirhan, MD, Jocelin Huang, MD, Chin-Yang Li, MD, Ayalew Tefferi, MD

Blood (2007) 110 (11): 3539.

https://doi.org/10.1182/blood.V110.11.3539.3539

Published: 2007

NARROW

Weight Loss, Splenomegaly, and Hypocholesterolemia in Myeloproliferative Neoplasms: Patterns and Relevance from the Pre JAK2 Inhibitor Era.

Red Blood Cell Transfusion Requirement at Diagnosis Adversely Affects Both Overall and Leukemia-Free Survival in Primary Myelofibrosis - Increased Serum Ferritin or Total Transfusion Burden Does Not

Dynamics, and Prognostic Impact, of Weight Loss in Primary Myelofibrosis

Hypocholesterolemia Is Independently Associated with Decreased Survival in Patients with Primary Myelofibrosis: An Analysis of Lipid Profiles in 558 Myeloproliferative Patients.

Erythropoietin Therapy Does Not Benefit Transfusion-Dependent Primary Myelofibrosis Patients and Treatment Response Is Infrequent with a Baseline Hemoglobin Level ≥ 10 g/dL.

Low JAK2 V617F Allele Burden in Primary Myelofibrosis, Compared to Either a Higher Allele Burden or Unmutated Status, Predicts Inferior Overall and Leukemia-Free Survival.

Erythropoiesis Stimulating Agents and the Risk of Leukemic Transformation in Primary Myelofibrosis.

The Presence of the JAK2 V617F Mutation in Primary Myelofibrosis and Its Allele Burden in Polycythemia Vera Predict Chemosensitivity to Hydroxyurea.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only